Document:

Exhibit
10.1

 

INTELLECTUAL
PROPERTY AGREEMENT

 

This
Intellectual Property Agreement (together with its exhibits, the “Agreement”), effective as of January
31, 2016 (the “Effective Date”), is made and entered into by and between: (a) Hewlett-Packard Development
Company, L.P., a Texas limited partnership having its principal place of business at 11445 Compaq Drive West, Houston, Texas 77070-1443
(“HPDC”), and HP, Inc., a Delaware corporation having its principal place of business at1501 Page Mill
Road, Palo Alto, California 94304, U.S.A. (“HPI”) (HPDC and HPI are collectively referred to herein
as “HP”), on the one hand; and (b) 3D Nanocolor Corp., a Delaware corporation having its principal place
of business at 11100 Santa Monica Blvd Suite 380, Los Angeles, CA 90025 U.S.A. (“Company”), on the other
hand. HP and Company may hereinafter be referred to collectively as the “Parties” and individually as
a “Party”.

 

WHEREAS,
HP has developed certain electro-kinetic display technology as described in further detail in Exhibit 1.9 attached
hereto.

 

WHEREAS
Company desires to have a research license to determine the feasibility of incorporating such technology in its products,
and HP desires to grant such a license;

 

WHEREAS,
Company in addition desires an option to purchase, and HP desires to sell an option to purchase the Assignable Patents (as defined
below), subject to the terms and conditions set forth in this Agreement.

 

NOW
THEREFORE, in consideration for the mutual covenants contained herein and other good and valuable consideration, the sufficiency
of which is hereby acknowledged, the Parties agree as follows:

 

		1	Definitions

 

		1.1	“Affiliate”
                                         means, with respect to a Party, any entity that Controls, is Controlled by, or is under
                                         common Control with such Party.

 

		1.2	“Assignable
                                         Patents” means, collectively the patent(s) and the patent application(s) set forth
                                         in Exhibit 1.2 hereto.

 

		1.3	“Assignment
                                         Option” means the option specified in Section 2.3.

 

		1.4	“Control”
                                         means the: (i) ownership of, or power to control the voting of, more than 50% of the
                                         outstanding shares representing the right to vote for directors or other managing officers
                                         of such an entity; or (ii) for an entity that does not have outstanding shares, more
                                         than 50% of the legal or beneficial ownership interest representing the right to make
                                         decisions for such entity; or (iii) possession of the power to direct or cause the direction
                                         of the management and policies of such entity, whether by contract or otherwise. An entity
                                         shall be an Affiliate only for so long as such “Control” exists.

 

		1.5	“Closing
                                         Date” is two (2) years from the Effective Date, or such longer period as the Parties
                                         may agree, and further subject to the provisions of Section 2.3.

 

HP/
3D Nanocolor Confidential

Intellectual
Property Agreement

 

     

     

    

 

 

		1.6	“Field
                                         of Use” means any field including imaging applications (which for purposes hereof,
                                         means at least 126 single color pixels per inch or, equivalently, 42 side-by-side full-color
                                         pixels per inch) and signage, but excluding the tinting of windows, visors, goggles,
                                         and eyeglasses.

 

		1.7	“Follow-on
                                         Patents” means (a) all extensions, renewals, reissues, and reexaminations of the
                                         issued patents of the Assignable Patents and (b) all applications claiming any right
                                         of priority to or through the patent applications of the Assignable Patents (and all
                                         patents issuing on such applications), filed or applied for by Company, by any of Company’s
                                         Affiliates or by any subsequent successors to, or assigns of, any of the same in any
                                         country after the Closing Date.

 

		1.8	“HP
                                         Group” means HP and its Affiliates (current and future, and its and their successors
                                         in interest).

 

		1.9	“HP
                                         Technology” the IP described in Exhibit 1.9 attached hereto.

 

		1.10	“Improvement
                                         Patents” means any patented or patent-pending improvements made by or for Company
                                         or its Affiliates to the HP Technology, whether such improvements are created by way
                                         of optimization, enhancement or otherwise, and includes without limitation any patentable
                                         inventions: (i) used in manufacturing, or otherwise incorporated in, a Licensed Product:
                                         (ii) that was created with reference to the HP Technology; or (iii) that otherwise requires
                                         the practice of any Assignable Patent.

 

		1.11	“Intellectual
                                         Property” or “IP” means discoveries, inventions, developments, improvements,
                                         works of authorship, mask works, identifying marks, trade dress, confidential or proprietary
                                         information, know-how, designs, processes, technologies and other such items for which
                                         Intellectual Property Rights may be secured.

 

		1.12	“Intellectual
                                         Property Rights” or “IPR” means all rights in patents, patent applications,
                                         utility models, design rights, copyrights, moral rights, trade secrets, mask work registrations,
                                         trademarks, service marks and other similar rights.

 

		1.13	“Knowledge
                                         of HP” means the specific knowledge of HP’s patent counsel and business persons
                                         providing support for this Agreement on the Effective Date, following a diligent search
                                         of HP’s database routinely used for tracking its patent agreements.

 

		1.14	“Licensed
                                         Product” means any product, product line, service, device, system, component, hardware,
                                         software or any combination of the foregoing, which is made, used, imported, exported,
                                         distributed, sold, offered for sale, or developed by a Party and which, in the absence
                                         of a license granted under this Agreement, would infringe at least one claim of one of
                                         the Assignable Patents or the Follow-on Patents or otherwise uses the HP Technology in
                                         its use or manufacture.

 

		1.15	“Open
                                         Source License” means any license that (a) has been approved as an open source
                                         license by the Open Source Initiative; and/or (b) provides as a condition or covenant
                                         of use, modification or distribution of the licensed software, that such software, or
                                         other software derived from such software: (i) be redistributable at no charge, (ii)
                                         be licensable and/or redistributed to third parties, and that derivative works of such
                                         software may be made and distributed, or (iii) be distributed or otherwise disclosed
                                         or made available in source code form.

 

    	HP/ Caldera Confidential	 	Page 2
	Intellectual Property Agreement	 	 

     

    

 

		1.16	“Purchase
                                         Price” has the meaning set forth in Section 4.2.1.

 

		1.17	“Subsidiary”
                                         means, with respect to a Party, any entity which is Controlled by the Party.

 

		1.18	“Standards-Related
                                         Actions” means to (i) disclose to a standards organization (whether open, proprietary,
                                         or otherwise) any patent that may be essential or necessary for implementation of, or
                                         otherwise reads on, a standards specification promulgated by the standards organization, (ii) provide an assurance to a standards organization (whether open, proprietary, or
                                         otherwise) of a willingness to license or grant a license under reasonable and non-discriminatory
                                         terms, royalty-free or royalty-bearing, one or more patents that are essential or necessary
                                         for implementation of, or otherwise reads on, a standards specification promulgated by
                                         the standards organization, or (iii) submit one or more patents to a patent pool or a
                                         patent pool’s agent for inclusion in the pool’s licensing activities.

 

		1.19	“Third
                                         Party” means any Person other than Company, HP or their respective Affiliates.

 

		2	Technology
                                         Transfer; Research License, Production Option And Ownership

 

		2.1	Technology
                                         Transfer. HP shall transfer to Company, and Company shall take title
                                         to, the tangible HP Technology deliverables specified in Exhibit 1.9 at HP’s
                                         facilities in Corvallis, Oregon within 15 days of the Effective Date. In addition, HP
                                         shall provide up to thirty (30) hours of telephonic or e-mail consulting from such facilities
                                         with respect to the HP Technology on an “as available” basis, said consulting
                                         to end no later than April 30, 2016.

 

		2.2	Research
                                         License. HP hereby grants to Company and its Subsidiaries, a license,
                                         in and to the HP Technology and under the Assignable Patents, to design, make, have made
                                         and use Licensed Products for research purposes only, including providing prototypes
                                         thereof to prospective customers to determine feasibility and customer acceptance.

 

		2.3	Patent
                                         Assignment Option. Company shall have the exclusive option to acquire
                                         the Assignable Patents in accordance with, and subject to, the terms of this Section
                                         2.3 (the “Assignment Option”). The Assignment Option will be deemed exercised
                                         if:

 

		2.3.1	Company
                                         provides HP notice at least sixty (60 days before the Closing Date of its intent to exercise
                                         such option; and

                                                                                

	 	 	 
	 	2.3.2	Company
                                         makes the payment specified in Section 4.2.1 within sixty (60) days of said notice, then
                                         effective as of such date (which date of payment shall thereafter be considered the Closing
                                         Date).

 

If
the Assignment Option is exercised, then HP agrees to the assignment and transfer of the Assignable Patents in accordance with
Section 3.

 

    	HP/ Caldera Confidential	 	Page 3
	Intellectual Property Agreement	 	 

     

    

 

		2.4	Covenant
                                         Not to License. For two (2) years from the Effective Date, other than
                                         as set forth in this Section 2.4, HP agrees not to license, transfer, pledge, offer to
                                         option, encumber, sell, assign or otherwise dispose of the HP Technology, or the Assignable
                                         Patents to any Third Party. The foregoing shall not apply to: (i) licenses executed prior
                                         to the Effective Date or options to license executed prior to the Effective Date that
                                         are exercised thereafter; (ii) patent cross-licenses or broad licenses, regardless of
                                         their execution date, that do not specifically (a) enumerate the Assignable Patents or
                                         (b) otherwise contemplate disclosure of the HP Technology; or (iii) litigation settlement
                                         agreements between HP or its Subsidiaries and any Third Party.

 

		2.5	Ownership.
                                         Subject to the licenses granted hereunder, as between the Parties, all right, title
                                         and interest in and to:

 

		2.5.1	The
                                         HP Technology remains with HP; provided, however, that title to the tangible embodiments
                                         of the HP Technology listed as “Sample Material” under Exhibit 1.9 shall
                                         transfer to Company upon its exercise of the Assignment Option;

 

		2.5.2	The
                                         Improvement Patents remains with Company; and

 

		2.5.3	The
                                         Assignable Patents and any Follow-On Patents remain with HP unless and until the Assignment
                                         Option is exercised.

 

		2.6	Confidentiality.
                                         HP may disclose information to Company that HP considers to be proprietary and/or confidential,
                                         either marked as “Confidential” at the time of disclosure or treated as confidential
                                         at the time of disclosure and within 30 days thereafter confirmed in writing as being
                                         confidential (in all such cases, “Confidential Information”). Company will
                                         use Confidential Information only for purposes relating to this Agreement (including
                                         without limitation, to exercise the licenses granted under Section 2.2) and will protect
                                         such Confidential Information by using the same degree of care, but no less than a reasonable
                                         degree of care, to prevent the unauthorized use, dissemination or publication of such
                                         Confidential Information as Company uses to protect its own information of like nature.
                                         Company may share this Confidential Information to its legal and financial counsel and
                                         other professional advisors, but subject to their being bound by confidentiality obligations
                                         at least as strict as provided herein. The obligation to protect Confidential Information
                                         under this Section 2.6 does not extend to any information that:

 

		2.6.1	Was
                                         in Company’s possession prior to its receipt under this Agreement;

 

		2.6.2	Is
                                         or becomes publicly known without breach of this Agreement; 
	 	 	 
	 	2.6.3	 Is rightfully received
                                         by Company from any Third Party without accepting a duty of confidentiality;

 

		2.6.4	Is
                                         disclosed by HP to any Third Party without imposing a duty of confidentiality;
	 	 	 
	 	2.6.5	 Is independently developed by Company;

 

		2.6.6	Is
                                         disclosed with written permission from HP; or

 

    	HP/ Caldera Confidential	 	Page 4
	Intellectual Property Agreement	 	 

     

    

 

		2.6.7	Is
                                         required to be disclosed pursuant to a subpoena, court order or other operation of law;
                                         provided that Company has promptly notified HP and HP has the opportunity to contest
                                         the need for such disclosure, or to seek a protective order therefore.

 

The
provisions of this Section 2.6 shall expire upon Company exercising the Assignment Option. While the terms of this Agreement shall
be considered confidential, the foregoing shall not, however, be construed as prohibiting either Party from disclosing the existence
of this Agreement or the fact that the Assignable Patents were assigned by HP to Company, registering the assignment of Assignable
Patents; or from referencing this Agreement in other agreements subject to confidentiality terms and conditions similar to those
contained herein. Furthermore, HP may disclose the applicable terms of Section 5 as reasonably necessary to confirm to third parties
the existence and scope of rights or immunities granted or sublicensed thereunder. Any other public disclosure by Company, such
as a press release or other communique, regarding this Agreement shall require HP’s prior consent, not to be unreasonably
withheld or delayed.

 

		2.7	Prosecution
                                         and Maintenance. Unless and until the Assignment Option is exercised, HP shall be
                                         responsible for the prosecution and maintenance, including the payment of all associated
                                         fees, of the Assignable Patents, after which the responsibilities for which shall be
                                         in Company’s sole discretion. Company is responsible for prosecution and maintenance
                                         of the Improvement Patents, the responsibility being subject to Company’s sole
                                         discretion.

 

		3	Assignment
                                         And Transfer Of Patents

 

The
provisions of this Section 3 shall be effective and only apply if Company exercises the Assignment Option.

 

		3.1	Patent
                                         Assignment. Subject to all rights granted to others prior to or concurrent with the
                                         Closing Date as set forth in Section 6, and HP’s reservation of rights set forth
                                         in Section 5, HP hereby sells, assigns, transfers and conveys to Company, effective as
                                         of the Closing Date, all of HP’s right, title and interest in and to the Assignable
                                         Patents, including without limitation, the right to sue for injunctive relief and damages
                                         (including based on provisional rights related to published patent applications among
                                         the Assignable Patents) for infringement of any of the Assignable Patents accruing at
                                         any time prior to, on, or after the Closing Date (subject to Section 6.2).

 

		3.1.1	Subsequent
                                         Transfer of Patents. Company shall ensure (whether by operation of law or otherwise)
                                         that any transfer, by assignment or otherwise, of any of the Assignable Patents, Follow-on
                                         Patents or any Improvement Patents by Company to any party shall be subject to all of
                                         HP’s and its Affiliates’ rights under this Agreement.

 

		3.1.2	Perfecting
                                         Title. Following the Closing Date and subject to Section 3.5, upon Company’s
                                         request, HP shall reasonably cooperate with Company to perfect, record and secure title
                                         in and to the Assignable Patents, at Company’s expense.

 

    	HP/ Caldera Confidential	 	Page 5
	Intellectual Property Agreement	 	 

     

    

 

		3.2	Company
                                         Responsibilities. Company shall be solely responsible for all actions and all costs
                                         whatsoever, including but not limited to taxes, attorneys’ fees and patent office
                                         fees in any jurisdiction, associated with the perfection of Company’s rights, title,
                                         and interest in and to each Assignable Patent and recordation thereof. HP’s obligation
                                         to execute and deliver to Company the documents specified in Section 3.1 constitutes
                                         HP’s entire obligation to transfer to Company any materials relating to the Assignable
                                         Patents. Furthermore, Company shall be solely responsible for all actions and all costs,
                                         including attorneys’ fees and patent office fees in any jurisdiction, for prosecution
                                         or maintenance of the Assignable Patents having a due date on or after the Closing Date.

 

		3.3	No
                                         Other Rights. Except for the assignment of Assignable Patents and the licenses to
                                         the HP Technology as expressly set forth in this Agreement, no license, immunity, ownership
                                         interest, or other right is granted to Company under this Agreement, either directly
                                         or by implication, estoppel, or otherwise. Without limiting the foregoing, no license
                                         or other right is granted by this Agreement to practice any other patent, application
                                         for patent, or other intellectual property right of HP, even if required for the practice
                                         of an Assignable Patent or sharing a common priority with an Assignable Patent.

 

		3.4	Employee/Inventors.
                                         Following the Closing Date and subject to Section 3.5, upon Company’s reasonable
                                         request, HP shall reasonably cooperate with Company to make HP’s employees or named
                                         inventors of the Assignable Patents that are employed by HP at the time of Company’s
                                         request available as needed to facilitate prosecution of the Assignable Patents.

 

		3.5	Reimbursement.
                                         Company shall reimburse HP for any reasonable out of pocket costs (including reasonable
                                         hourly rates for the employees/inventors that may cooperate under Section 3.4) and expenses
                                         that HP incurs in complying with its obligations under Sections 3.1.2 and 3.4.

 

		4	Payment

 

		4.1	Research
                                         License Fee. Company shall pay HP the non-refundable, non-creditable amount of Two
                                         Hundred Thousand Dollars and Zero Cents (U.S.$200,000.00) payable in accordance with
                                         the following schedule:

 

		4.1.1	One
                                         Hundred Thousand Dollars and Zero Cents (U.S.$100,000.00) upon completion of the technology
                                         transfer contemplated under Section 2.1; and

 

		4.1.2	One
                                         Hundred Thousand Dollars and Zero Cents (U.S.$100,000.00) upon the first anniversary
                                         of the Effective Date.

 

		4.2	Assignment
                                         Option Exercise. In the event that Company exercises the Assignment Option, Company
                                         shall pay HP:

 

		4.2.1	The
                                         non-refundable, non-creditable amount of One Million Four Hundred Thousand Dollars and
                                         Zero Cents (U.S.$1,400,000.00) (the “Purchase Price”); and

 

    	HP/ Caldera Confidential	 	Page 6
	Intellectual Property Agreement	 	 

     

    

 

		4.2.2	A
                                         running royalty of Three Percent (3.0%) of the gross revenues received by Company and
                                         its Affiliates for the sale, rental, license or other disposition of Licensed Products.

 

Company
acknowledges and agrees that HP may terminate this Agreement upon notice to Company with no liability to Company whatsoever if
HP does not receive the Purchase Price by or before the last possible date that can qualify as the Closing Date under Section
1.4.

 

		4.3	Manner
                                         of Payment. Payment that is due under Section 4.1 or 4.2 shall be made by wiretransfer
                                         to:

 

Bank
of America,

1850
Gateway Boulevard

Concord,
CA 94520

 

Account
name: Hewlett-Packard Development Company

ABA No. 026009593

Swift
No. BOFAUS3N

Account
Number: 3752072176

 

with
notice as to the confirmation of wire transfer to be sent to the HPI address specified in Section 10.5, and an electronic mail
copy thereof sent to IPL.Wiretransfer@hp.com.

 

		4.4	Late
                                         Payments. Any delay by Company in transmitting a payment due hereunder shall constitute
                                         a material breach of this Agreement. Company must correct any discrepancy in payment
                                         within 30 days of discovering the discrepancy or being notified thereof by HP. If a required
                                         payment is delayed or when a discrepancy is corrected, Company shall pay to HP simple
                                         interest calculated at an annual rate equal to the U.S. prime rate as published by the
                                         Wall Street Journal for the date on which such amounts first became past due, to be paid
                                         by Company for each month or portion thereof that the payment was delayed or the discrepancy
                                         was outstanding. Interest is in addition to any other remedies HP may have under this
                                         Agreement, at law or in equity.

 

		4.5	Taxes.
                                         Company shall pay all taxes (including without limitation sales, use, value-added,
                                         and similar taxes) arising from the payments made by Company to HP under this Agreement,
                                         except for taxes based solely upon HP's net income and legally required withholding taxes.
                                         Where applicable, HP shall invoice Company for such taxes and Company shall remit the
                                         amount of such taxes to HP or provide HP with the appropriate exemption certificate.
                                         In any case, where taxes are withheld, Company shall provide HP with all documentation
                                         relating to withheld taxes, including receipts necessary to claim the applicable credit.
                                         Other than taxes based solely upon HP's income and legally required withholding taxes,
                                         in the event that taxes are legally imposed initially or are later assessed by any taxing
                                         authority upon HP, then Company shall reimburse HP for such taxes, plus any interest
                                         suffered by HP, within sixty (60) days.

 

    	HP/ Caldera Confidential	 	Page 7
	Intellectual Property Agreement	 	 

     

    

 

		4.6	Royalty
                                         Reports, Payments, and Accounting.

 

		4.6.1	Royalty
                                         Payment and Report. Within 30 days after the end of each calendar quarter after the
                                         exercise of the Assignment Option, Company will make a written report of proceeds (the
                                         “Royalty Report”) due under Section 4.2.2 for the preceding
                                         calendar quarter. The Royalty Report is due even if revenues are zero. The Royalty Report
                                         will take the form of Exhibit 4.6.1 attached hereto. Within 30 days following
                                         the end of each calendar quarter, Company will make the payment due HP of royalties for
                                         the time period covered by such report.

 

		4.6.2	Address.
                                         The Royalty Report will be sent to the following address:

 

HP
Inc.

1501
Page Mill Road, M/S 1560

Palo
Alto, CA 94304

U.S.A.

 

ATT:
IPSL Royalty Report/Contract Compliance

 

With
an email copy of the Royalty Report to: IPL.Royalty@hp.com. The foregoing addresses may be changed by HP by reasonable advance
notice.

 

		4.6.3	Late
                                         Reports. Any delay by Company in submitting a Royalty Report will constitute a material
                                         breach of this Agreement.

 

		4.6.4	Accounting.
                                         Company will keep and maintain records for a period of 5 years showing the sale,
                                         license, lease, use or other disposition of Licensed Product(s). Such records will include
                                         general ledger records showing cash receipts and expenses, and records that include production
                                         records, customers, serial numbers and related information in sufficient detail to enable
                                         the royalties payable hereunder by Company to be determined. Company will maintain such
                                         records in accordance with “Generally Accepted Accounting Principles,” “International
                                         Financial Reporting Standards” or other then-applicable generally accepted accounting
                                         principles. Company will permit its books and records to be examined by an independent
                                         auditing firm selected by HP from time to time to the extent necessary to verify the
                                         Royalty Reports. Any such examination will be made at the expense of HP, except in the
                                         event that the results of the audit reveal an underreporting of royalties due HP of 3%
                                         or more, then the costs of such examination will be borne by Company. Within 30 days
                                         after receiving notice from HP of any underpayment identified by such examination, Company
                                         will pay: (i) any underpayments plus interest calculated from the date when such underpayment
                                         should have been paid; and (ii) the cost of such examination, if required as set forth
                                         above. If the examination shows Company overpaid, Company will credit such discrepancies
                                         against future payments owing hereunder.

 

    	HP/ Caldera Confidential	 	Page 8
	Intellectual Property Agreement	 	 

     

    

 

		5	Reserved
                                         rights

 

The
provisions of this Section 5 shall be effective and only apply if Company exercises the Assignment Option.

 

		5.1	Retained
                                         License. HP reserves and retains, for the benefit of the HP Group), and/or Company
                                         hereby grants back to HP Group, as the case may be, a worldwide, fully paid-up, royalty-free,
                                         irrevocable, non-exclusive license under the Assignable Patents and any Follow-on Patents
                                         and Improvement Patents to make, have made, use, sell, offer for sale, import, export,
                                         and otherwise dispose of or exploit any product or service of HP Group within the Field
                                         of Use, and to practice any method, and to authorize third parties to do any of the foregoing
                                         on behalf of HP Group. This license shall remain in force for the full term of any Assignable
                                         Patents and any Follow-on Patents and Improvement Patents.

 

		5.2	Sublicensing.
                                         HP Group may sublicense any or all of the rights described in Section 5.1:

 

		5.2.1	to
                                         any Third Party for the development or manufacture of HP Group’s products or services,
                                         or components thereof, and solely on behalf of HP Group;

 

		5.2.2	to
                                         a Third Party to whom HP Group has provided or provides products or services solely (i)
                                         to the extent reasonably required for the enjoyment of those products or services; or
                                         (ii) to the extent required to avoid liability or obligation under a bona fide indemnity
                                         entered into in conjunction with those products or services;

 

		5.2.3	to
                                         the extent required by any legally binding duty or obligation to grant any Third Party
                                         any license, covenant not to sue, or similar right under the Assignable Patents and any
                                         Follow-on Patents, where such duty or obligation existed (or is based on or arises out
                                         of any contract, promise, conduct, or action that existed or occurred) prior to the Closing
                                         Date; and

 

		5.2.4	to
                                         any entity that, at any time after the Closing Date, ceases to be an Affiliate of HP,
                                         or acquires an Affiliate of HP, or acquires any product line or service line of HP Group;
                                         provided, however, that the scope of any such sublicense shall be limited
                                         to: (i) the products and services of the applicable Affiliate, product line, or service
                                         line that existed or were in development immediately prior to the granting of the sublicense;
                                         and (ii) any future versions of such products and services substantially derived therefrom.

 

		5.3	Anti-Laundry
                                         Provision. For clarity, HP understands and acknowledges that the licenses retained
                                         under Sections 5.1 and 5.2 cover only the products and services sold to, by, through
                                         or on behalf of HP Group, and do not cover: (i) transactions that the HP Group enter
                                         into or otherwise arrange with a Third Party predicated, in whole or substantial part,
                                         on the Third Party’s or HP Group’s part, to purposefully avail itself of
                                         the licenses granted under Sections 5.1 and 5.2; or (ii) products the designs of which
                                         are received in substantially completed form from a Third Party which HP Group merely
                                         manufacture for sale only by or on behalf of such Third Party; provided, however,
                                         that the application of brands or marks of a Third Party to products or services designed
                                         and manufactured by HP Group (ordinarily known as private labeling) shall not be considered
                                         unlicensed laundering activity.

 

    	HP/ Caldera Confidential	 	Page 9
	Intellectual Property Agreement	 	 

     

    

  

		5.4	Further
                                         Assistance. Company shall execute all documents and instruments, and shall do all
                                         lawful acts, in each case as may be reasonably necessary, at HP’s request, to record
                                         or perfect the reserved rights of HP Group under this Agreement. HP shall reimburse Company
                                         for reasonable expenses incurred under this Section 5.4 that have been approved in advance.

 

		5.5	Company’s
                                         Joinder of HP. Company shall not: (i) voluntarily join or implead an HP Group entity,
                                         either directly or through an intermediary or affiliate, as a co-party plaintiff in any
                                         litigation or administrative proceeding brought by Company and Affiliates alleging the
                                         infringement by a Third Party of the Assignable Patents; or (ii) undertake voluntarily
                                         a position that an HP Group entity is or should be a necessary or indispensable co-party
                                         plaintiff for the purpose of any litigation or administrative proceeding brought by Company
                                         alleging the infringement by any Third Party of the Assignable Patents. If an HP Group
                                         entity is involuntarily joined as a co-party plaintiff, Company shall take all steps
                                         reasonably requested by HP to attempt to remove them from the litigation.

 

		5.6	Indemnity.
                                         From and after the Closing Date, Company shall (or shall cause one or more of its
                                         Affiliates to) promptly and fully reimburse, indemnify and hold harmless HP Group for,
                                         from and against any and all liabilities, losses, costs and expenses, of whatever kind
                                         or nature, incurred, suffered or sustained by HP Group from and after the Closing Date
                                         arising out of, or in relation to, (a) Company’s defense, enforcement or licensing
                                         of the Assignable Patents or (b) any litigation or judicial or administrative action
                                         relating to any Assignable Patent in which an HP Group entity or their respective current
                                         or former employees are (i) named as a party, respondent or otherwise in any such litigation
                                         or action, (ii) obligated to provide testimonial, documentary or other evidence under
                                         any order, subpoena or other formal process, (iii) otherwise obligated under applicable
                                         law to take any action where failure to take action could reasonably be expected to expose
                                         HP Group or its employees to liability of any kind, such foregoing liabilities, losses,
                                         costs and expenses to include any discovery or travel costs, settlement, judgment, employee
                                         time and attorneys’ fees and expenses.

 

		6	Prior
                                         Commitments

 

The
provisions of this Section 6 shall be effective and only apply if Company exercises the Assignment Option.

 

	6.1	Encumbrances.
                                         Company accepts the assignment of the Assignable Patents under this Agreement subject
                                         to all rights granted to others prior to or concurrent with the Closing Date.

 

	6.2	Retained
                                         Royalties. HP reserves and retains, for the benefit of itself and its Affiliates
                                         (and its and their successors and assigns), all rights to past, present, and future royalties
                                         and other consideration given or to be given in exchange for rights with respect to any
                                         Assignable Patent arising or accruing under agreements executed by HP or its Affiliates
                                         prior to the Closing Date. HP further reserves and retains all such royalties and other
                                         consideration arising out of or accruing under any license, sublicense, immunity or other
                                         right granted by HP or its Affiliates pursuant to Section 5.2.

 

    	HP/ Caldera Confidential	 	Page 10
	Intellectual Property Agreement	 	 

     

    

 

	6.3	Open
                                         Source Licenses. HP may have contributed computer code to an open source computer
                                         project or otherwise made computer code (collectively, the “Computer Code”)
                                         subject to the obligations of an Open Source License. To the extent that one or more
                                         claims of the Assignable Patents and any Follow-on Patents read on Computer Code, Company
                                         acknowledges that the Assignable Patents and any Follow-on Patents may be subject to
                                         the express or implied licensing obligations of an Open Source License. Accordingly,
                                         Company acknowledges and agrees that the sale and assignment of the Assignable Patents
                                         shall be subject to, and Company shall abide by, all obligations of any Open Source License
                                         governing such Computer Code.

 

	6.4	Standards
                                         Obligations. Company acknowledges that HP may have made or offered to make one or
                                         more of the Assignable Patents and any Follow-on Patents subject to the express or implied
                                         licensing obligations of a standards body prior to the Closing Date. Accordingly, Company
                                         acknowledges and agrees that the sale and assignment of the Assignable Patents shall
                                         be subject to, and Company shall abide by, all such preexisting obligations arising out
                                         of any Standards-Related Actions that relate to the Assignable Patents and any Follow-on
                                         Patents.

 

		7	Representations
                                         And Warranties

 

		7.1	Authority.
                                         Each Party represents and warrants on the Effective Date that it has the right and authority
                                         to enter into this Agreement, to grant the licenses, assignments and other rights it
                                         purports to grant hereunder, and to carry out its obligations hereunder.

 

		7.2	Title;
                                         No Liens; Maintenance Fees. HP represents and warrants on the Effective Date that:
                                         (a) it is the sole owner of the Assignable Patents, with the full right and power to
                                         assign each Assignable Patent as set forth in Section 3.1; (b) each Assignable Patent
                                         is free from all liens and security interests, and (c) none of the Assignable Patents
                                         are abandoned or have lapsed based on a failure to pay maintenance fees.

 

		7.3	Confirmed
                                         Unlicensed Companies. HP represents and warrants that to the Knowledge of HP, solely
                                         with respect to any of the entities explicitly set forth in Exhibit 7.3 (excluding
                                         any affiliates of such entities operated under a different name), no document was found
                                         purporting to grant a patent license to Assignable Patents, where such license can be
                                         determined through review of the document without an independent factual investigation
                                         to determine whether the Assignable Patent was implicated. Without limiting the foregoing,
                                         the following types of documents are excluded as a patent license: standards/open source
                                         commitments including those pursuant to Sections 6.3 and 6.4; product/supply agreements;
                                         software/technology licenses; development agreements; and services agreements.

 

    	HP/ Caldera Confidential	 	Page 11
	Intellectual Property Agreement	 	 

     

    

 

		7.4	Adjudications
                                         and Proceedings. HP represents and warrants that to the Knowledge of HP: (i) no court
                                         or other tribunal or administrative body has made a finding or adjudication, pursuant
                                         to any proceeding to which HP was a party, that any of the Assignable Patents for which
                                         the serial or patent numbers are explicitly listed in Exhibit 1.2 is invalid or
                                         unenforceable; and (ii) no Assignable Patent is the subject of a claim of invalidity
                                         or unenforceability in any pending judicial, administrative or other proceeding pursuant
                                         to which HP is a party.

 

		8	Term
                                         and Termination

 

		8.1	Term.
                                         Unless terminated under this Section 7, the term of this Agreement shall last until the
                                         last to expire of the Assignable Patents.

 

		8.2	Termination
                                         for Non-Exercise. HP may terminate this Agreement upon notice to Company in the event
                                         Company failed to exercise the Assignment Option by the Closing Date.

 

		8.3	Termination
                                         for Non-Payment. HP may terminate this Agreement in the event Company fails to make
                                         any payment specified hereunder when due and fails to pay such sum within 10 days after
                                         receipt of notice from HP.

 

		8.4	Termination
                                         for Cause. Either Party may terminate this Agreement for cause by notice to the other
                                         Party in the event the other Party materially breaches any provision of this Agreement
                                         and such breach is not cured within 30 days after receipt of notice from the non-breaching
                                         Party.

 

		8.5	Termination
                                         for Bankruptcy. HP has the right to terminate this Agreement upon notice to Company
                                         if Company: (i) enters into voluntary or involuntary bankruptcy; (ii) ceases to make
                                         payments to a substantial number of its creditors; (iii) ceases to conduct its business;
                                         (iv) makes or causes to be made an assignment of its assets or business, in whole or
                                         in part, for the benefit of its creditors; or (v) has a receiver or trustee appointed
                                         to administer all or a substantial part of its business or property.

 

		8.6	Termination
                                         for Force Majeure. Either Party has the right to terminate this Agreement in accordance
                                         with Section 10.10.

 

		8.7	Effect
                                         of Termination. A Party that terminates this Agreement as provided in this Section
                                         8 shall not be liable to the other Party for any termination charges or damages, including
                                         without limitation damages for goodwill, investments made, and the like. In the event
                                         of termination of this Agreement: (i) Company shall return all existing Confidential
                                         Information of HP provided hereunder and certify in writing destruction of all copies
                                         thereof.

 

		8.8	Survival.
                                         The following provisions shall survive expiration or termination of this Agreement
                                         for any reason: (i) any Party’s obligations to make payments required hereunder
                                         that have accrued before the effective date of termination; (ii) any cause of action
                                         or claim of either Party resulting from any breach or default of the other Party before
                                         the effective date of termination; and (iii) Sections 1, 2.5 – 2.6, 4.3 –
                                         4.5, 5 – 6 (if the Assignment Option is exercised), 8.7, 8.8, 9 and 10.

 

    	HP/ Caldera Confidential	 	Page 12
	Intellectual Property Agreement	 	 

     

    

 

		9	No
                                         Other Warranties; Limitation Of Liability

 

		9.1	NO
                                         OTHER WARRANTIES. NOTWITHSTANDING ANY OTHER PROVISION OF THIS AGREEMENT OR ITS EXHIBITS
                                         OR ANY OTHER COMMUNICATION BY HP: (A) EXCEPT AS PROVIDED IN SECTION 7, HP MAKES NO OTHER
                                         REPRESENTATIONS OR WARRANTIES, EXPRESS OR IMPLIED, WITH RESPECT TO THE ASSIGNABLE PATENTS,
                                         OR THE HP TECHNOLOGY; (B) HP SPECIFICALLY DISCLAIMS ANY REPRESENTATION OR WARRANTY REGARDING
                                         THE VALIDITY OR ENFORCEABILITY OF ANY ASSIGNABLE PATENT; AND (C) IN NO EVENT SHALL HP
                                         HAVE ANY LIABILITY ON ACCOUNT OF COMPANY’S INFRINGEMENT OF ANY THIRD-PARTY PATENTS
                                         OR OTHER RIGHTS BY REASON OF PRACTICING OR LICENSING THE ASSIGNABLE PATENTS OR HP TECHNOLOGY.

 

		9.2	EXCLUSION
                                         OF CERTAIN DAMAGES. HP SHALL NOT BE LIABLE TO COMPANY FOR ANY CONSEQUENTIAL, INCIDENTAL,
                                         SPECIAL OR PUNITIVE DAMAGES, OR FOR ANY COSTS OF COVER, LOSS OF PROFITS OR GOODWILL,
                                         OR INTERRUPTION OF BUSINESS, UNDER OR IN RELATION TO THIS AGREEMENT, WHETHER BASED ON
                                         BREACH OF WARRANTY, CONTRACT, TORT, NEGLIGENCE, STRICT LIABILITY OR ANY OTHER THEORY,
                                         AND WHETHER OR NOT COMPANY WAS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

 

		9.3	LIMITATION
                                         OF LIABILITY. HP’S CUMULATIVE LIABILITY TO COMPANY FOR BREACHES OF THIS AGREEMENT,
                                         INCLUDING BUT NOT LIMITED TO BREACHES OF THE REPRESENTATIONS AND WARRANTIES SET FORTH
                                         IN SECTION 7, SHALL NOT EXCEED THE PURCHASE PRICE. WITHOUT LIMITING THE FOREGOING, HP’S
                                         LIABILITY TO COMPANY FOR BREACHES ASSOCIATED WITH A PARTICULAR PATENT INCLUDED IN THE
                                         ASSIGNABLE PATENTS, INCLUDING BUT NOT LIMITED TO, ANY BREACHES OF THE REPRESENTATIONS
                                         AND WARRANTIES GIVEN BY HP IN SECTION 7, SHALL IN NO EVENT EXCEED A PRO-RATED PORTION
                                         OF THE PURCHASE PRICE. IN NO EVENT SHALL HP HAVE ANY LIABILITY ON ACCOUNT OF COMPANY’S
                                         INFRINGEMENT OF ANY THIRD PARTY PATENTS OR OTHER THIRD PARTY INTELLECTUAL PROPERTY RIGHTS.

 

		10	Miscellaneous

 

		10.1	Assignment.
                                         HP and its Affiliates may assign their respective rights in this Agreement to their respective
                                         successors in interest. Company may assign this Agreement upon a merger, reorganization,
                                         acquisition, sale of all or substantially all its assets, or other transfer of all of
                                         the Assignable Patents to a Third Party (the “Subsequent Assignee”), provided
                                         that (a) Company remains liable jointly and severally with Subsequent Assignee for all
                                         obligations of Company under this Agreement and (b) Subsequent Assignee agrees in writing
                                         to be bound by the terms and conditions applicable to Company with respect to the Assignable
                                         Patents. Company shall ensure (whether by operation of law or otherwise) that any transfer,
                                         by assignment or otherwise, of any of the Assignable Patents or any Follow-on Patents
                                         by Company to any party shall be subject to all of HP Group’s rights under this
                                         Agreement.

 

    	HP/ Caldera Confidential	 	Page 13
	Intellectual Property Agreement	 	 

     

    

 

		10.2	Governing
                                         Law; Forum and Venue. This Agreement shall be governed and construed in accordance
                                         with the laws of the State of Delaware, without regard to or application of its conflict
                                         of laws, rules or principles. Any suit, action or proceeding arising out of or relating
                                         to this Agreement shall be brought exclusively in the federal or state courts located
                                         in Delaware, and each party irrevocably consents to the jurisdiction of and venue in
                                         any such court for purposes of any such suit, action or proceeding.

 

		10.3	Entire
                                         Agreement. The terms and conditions of this Agreement, including its exhibits, constitute
                                         the entire agreement among the Parties with respect to the subject matter hereof, and
                                         merge and supersede all prior and contemporaneous agreements, understandings, negotiations
                                         and discussions with respect to such subject matter. No amendments, modifications or
                                         waivers shall be effective unless in writing and signed by duly authorized representatives
                                         of Company, HPDC, and HPI.

 

		10.4	Counterparts.
                                         This Agreement may be executed in multiple counterparts, each of which shall be deemed
                                         an original, but all of which together shall constitute one and the same instrument.
                                         An electronic transmission of this Agreement by a Party containing a signature page that
                                         has been executed on behalf of that Party shall constitute a valid signature of that
                                         Party.

 

		10.5	Notices.
                                         All notices required or permitted to be given hereunder shall be in writing, shall make
                                         reference to this Agreement, and shall be delivered by recognized overnight delivery
                                         services such as FedEx, UPS or DHL, by hand, by prepaid air courier or by registered
                                         or certified airmail, postage prepaid, addressed as follows:

  

	 	If
    to Company:	If
    to HP: 
	 	 	 
	 	3D
    Nanocolor Corp.	HP
    Inc.
	 	11100
    Santa Monica Blvd	1501
    Page Mill Road
	 	Suite
    380	Building
    5M
	 	Los
    Angeles, CA 90025	Palo
    Alto, CA 94304
	 	Attention:
    Timothy Koch	Attention:
    DGC, Intellectual Property

 

Such
notices shall be deemed served when received by addressee or, if delivery is not accomplished by reason of some fault of the addressee,
when tendered for delivery. Either Party may give written notice of a change of address and, after notice of such change has been
received, any notice or request shall thereafter be given to such Party at such changed address.

 

    	HP/ Caldera Confidential	 	Page 14
	Intellectual Property Agreement	 	 

     

    

 

		10.6	Relationship
                                         of Parties. The Parties hereto are independent contractors. Neither Party has any
                                         express or implied right or authority to assume or create any obligations on behalf of
                                         the other or to bind the other to any contract, agreement or undertaking with any Third
                                         Party. Nothing in this Agreement shall be construed to create a partnership, joint venture,
                                         employment or agency relationship between HP and Company.

 

		10.7	Severability.
                                         If any paragraph, provision, or clause in this Agreement shall be found or be held to
                                         be invalid or unenforceable in any jurisdiction in which this Agreement is being performed,
                                         the remainder of this Agreement shall be valid and enforceable and the Parties shall
                                         use good faith to promptly negotiate a substitute, valid and enforceable provision which
                                         most nearly effects the Parties’ intent in entering into this Agreement.

 

		10.8	Waiver.
                                         Failure by either Party to enforce any term of this Agreement shall not be deemed a waiver
                                         of future enforcement of that or any other term in this Agreement.

 

		10.9	Attorney
                                         Fees. In any litigation, arbitration, or other proceeding by which one party either
                                         seeks to enforce its rights under this Agreement (whether in contract, tort, or both)
                                         or seeks a declaration of any rights or obligations under this Agreement, the prevailing
                                         party shall be awarded its reasonable attorney fees, and costs and expenses incurred.

 

		10.10	Force
                                         Majeure. Neither Party shall be liable for any failure to fulfill its obligations
                                         hereunder due to acts or omissions of government or military authority, acts of God,
                                         terrorism, earthquakes, fires, floods, epidemics, riots, wars or other events beyond
                                         the reasonable control of that Party. Each Party shall give the other Party prompt written
                                         notice of any such condition. If a Party’s failure to fulfill its obligations hereunder,
                                         which such Party claims is excused by a force majeure event pursuant to this Section
                                         10.10, lasts longer than 90 days, the other Party may terminate this Agreement.

 

		10.11	Agreement
                                         Not Construed Against Drafter. The Parties acknowledge and agree that each has been
                                         represented by legal counsel of its choice throughout the negotiation and drafting of
                                         this Agreement, that each has participated in the drafting thereof, and that this Agreement
                                         shall not be construed in favor of or against either Party solely on the basis of a Party’s
                                         drafting or participation in the drafting of any portion of this Agreement.

 

    	HP/ Caldera Confidential	 	Page 15
	Intellectual Property Agreement	 	 

     

    

 

IN
WITNESS WHEREOF, HPI and HPDC have executed this Intellectual Property Agreement by their duly authorized representatives as
of the Effective Date:

 

	HP
    Inc.	 
	 	 
	By:	/s/
Annette Friskopp	 
	Printed Name: 	Annette
    Friskopp	 
	Title:	HP
    GM Specialty Printing Systems	 
	Date:	January 29, 2016	 
	 	 	 
	Hewlett-Packard
    Development Company, L.P.	 
	 	 	 
	By:
    HPQ Holdings, LLC, its General Partner	 
	 	 	 
	By:	/s/
Dan Croft	 
	Printed Name: 	Dan
    Croft	 
	Title:	Director
    of Intellectual Property Sales and Licensing	 
	Date:	30-January-2016	 

 

    	HP/ Caldera Confidential	 	Page 16
	Intellectual Property Agreement	 	 

     

    

 

IN
WITNESS WHEREOF, Company has executed this Intellectual Property Agreement by their duly authorized representatives as of
the Effective Date:

 

3D
Nanocolor Corp.

 

	By:	/s/ Tim
    koch	 
	Printed Name:	Tim
    koch	 
	Title:	CTO
    - 3D Nanocolor Corp.	 
	Date:	January
    29, 2016	 

 

    	HP/ Caldera Confidential	 	Page 17
	Intellectual Property Agreement	 	 

     

    

 

List
of Exhibits

 

	Exhibit
    1.2	Assignable
    Patents
	Exhibit
    1.9	HP
    Technology
	Exhibit
    3.1.2	Form
    of Recordable Assignment
	Exhibit
    4.6.1	Form
    of Royalty Report
	Exhibit
    7.3	Unlicensed
    Companies

 

    	HP/ Caldera Confidential	 	Page 18
	Intellectual Property Agreement	 	 

     

    

 

Exhibit
1.2 – Assignable Patents

 

 

	HP
    Internal ID	 	Country	 	App.
    No.	 	Pat.
    No.	 	Title
	82250201	 	U.S.	 	12/411828	 	8018642	 	ELECTRO-OPTICAL
    DISPLAY
	82262213	 	U.S.	 	12/830581	 	8183757	 	DISPLAY
    ELEMENT
	82262189	 	U.S.	 	12/815993	 	8184357	 	DISPLAY
    ELEMENT
	82276163	 	U.S.	 	12/917672	 	8331014	 	PIGMENT-BASED
    INKS
	82262192	 	U.S.	 	12/815811	 	8384659	 	DISPLAY
    ELEMENT INCLUDING ELECTRODES AND A FLUID WITH COLORANT PARTICLES
	82259243	 	U.S.	 	12/626489	 	8432598	 	TRANSPARENT
    CONDUCTOR STRUCTURE
	82743867	 	U.S.	 	13/115754	 	8896906	 	INKS
    INCLUDING BLOCK COPOLYMER GRAFTED PIGMENTS VIA AZIDE CHEMISTRY

 

    	HP/ Caldera Confidential	 	Page 19
	Intellectual Property Agreement	 	 

     

    

 

Exhibit
1.9 – HP Technology

 

Documentation

 

Formulations
for black EKD fluid

Formulation
for structure resin

Embossing
patterns and design files

Electrical
driving schemes

 

Sample
Material 

 

Sample
Films

 

Available
raw materials for 500 ml of black EKD fluid

Embossing
Master Stamps

EKD
Cell Assembly fixtures

EKD
Evaluation Tool

 

    	HP/ Caldera Confidential	 	Page 20
	Intellectual Property Agreement	 	 

     

    

 

Exhibit
3.1.2 – Form of Recordable Assignment

 

Assignment
of Patent Rights

 

For
good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Hewlett-Packard Development Company,
L.P., a limited partnership duly organized and existing under the laws of the State of Texas and having its principal place of
business at 11445 Compaq Drive West, Houston, Texas 77070-1443, U.S.A. (“HPDC”), and HP Inc., a corporation
duly organized and existing under the laws of the State of Delaware and having its principal place of business at 1501 Page Mill
Road, Palo Alto, California 94304, U.S.A. (“HPI”) (HPDC and HPI are collectively referred to herein
as Assignor”), hereby grant and assign to 3D Nanocolor Corp. (“Assignee”) all of
Assignor’s right, title and interest in and to the United States Letters Patents identified in Exhibit A (collectively,
“Assigned Patents”), to have and to hold the same, for Assignee’s own use and enjoyment and for
the use and enjoyment of its successors and assigns, and the right to sue for damages for infringement of such Assigned Patents
accruing at any time prior to, on, and/or after the date hereof, for the full term or terms of all such Assigned Patents, subject
to all rights granted under the Assigned Patents to third parties prior to_______________[insert Closing Date].

 

IN
WITNESS WHEREOF, the Assignor executed this Assignment of Patent Rights by their duly authorized representatives as of the
Effective Date as set forth below:

 

HEWLETT-PACKARD
DEVELOPMENT COMPANY, L.P.

 

By:
  HPQ Holdings, LLC, its General Partner

 

	By:	 	 	Date:	 
	 	[Name], [Title]	 	 	 
	 	HPQ Holdings, LLC	 	 	 
	 	 	 	 	 
	HP INC.	 	 	 
	 	 	 	 	 
	By:	 	 	Date:	 
	 	[Name], [Title]	 	 	 
	 	HP Inc.	 	 	 

 

    	HP/ Caldera Confidential	 	Page 21
	Intellectual Property Agreement	 	 

     

    

 

Exhibit
4.6.1 – Form of Royalty Report

 

Contract
Title: 3D Nanocolor Corp - HP Intellectual Property Agreement (EKD)

 

Reporting
Period: _______________

 

Date
of Report:__________________________

 

	1	Gross
    revenues of Licensed Products	 
	2	Royalty
    due on Licensed Products (as determined by Section 4.2.2):	 
	3	Any
    Late fees & Interest if applicable:	 
	4	Total
    Payment Amount:	 

 

Payments
should be made to:

 

Bank
of America

ABA
No. 026009593

Swift No. BOFAUS3N

Account
Number: 3752072176

 

A
copy of this report should be sent to:

 

HP
Inc.

1501
Page Mill Road

Palo
Alto, CA 94304 U.S.A.

Attn:
IPSL Royalty/Contract Compliance

 

with
an email copy of the royalty report sent to: ipl.royalty@hp.com

Company Contact Information:

 

	NAME	 
	 	 
	PHONE	 
	 	 
	EMAIL ADDRESS	 
	 	 

    	HP/ Caldera Confidential	 	Page 22
	Intellectual Property Agreement	 	 

     

    

 

Exhibit
7.3 – Unlicensed Companies

 

		1.	3M

		2.	E
Ink Holdings

		3.	Merck
KGaA

		4.	Philips

		5.	Amazon

 

    	HP/ Caldera Confidential	 	Page 23
	Intellectual Property Agreement	 	 

     

    

 

 

 

Certificate
Of Completion

  

	Envelope Id: DFDCF82E673F4BB1BDC5539F22AB6C41	Status: Sent
	 	 
	Subject: Please DocuSign this document: EKD Intellectual Property Agreement - HP-3D Nanocolor

                    Source Envelope:
	 
	 	 	 
	Document Pages: 23	Signatures: 3	Envelope Originator:
	Certificate Pages: 5	Initials: 0	Dan Croft
	AutoNav: Enabled	 	3000 Hanover Street
	EnvelopeId Stamping: Enabled	 	MS 1050
	Time Zone: (UTC-08:00) Pacific Time (US & Canada)	 	Palo Alto, CA 93404
	 	 	dan.croft@hp.com
	 	 	IP Address: 12.19.232.10

 

Record
Tracking

 

	Status: Original	Holder: Dan Croft	Location: DocuSign
	1/29/2016 7:27:14 AM	dan.croft@hp.com	 
	 	 	 
	Signer Events	Signature	Timestamp
	 	 	 
	Annette Friskopp	 	Sent: 1/29/2016 7:33:53 AM
	annette.m.friskopp@hp.com	 	 
	GM Specialty Printing Systems	 	 
	HP Central Account 2	 	 
	Security Level: Email, Account Authentication	 	 
	(None)	 	 
	Electronic Record and Signature Disclosure:	 	 
	Not Offered	 	 
	ID:	 	 
	 	 	 
	Tim Koch	 	Sent: 1/29/2016 7:33:53 AM
	tim.koch@3dnanocolor.com	 	Viewed: 1/29/2016 8:23:20 AM
	Security Level: Email, Account Authentication	 	Signed: 1/29/2016 8:24:58 AM
	(None)	Using IP Address: 73.25.113.203	 
	 	 	 
	Electronic Record and Signature Disclosure:	 	 
	Accepted: 1/29/2016 8:23:20 AM	 	 
	ID: cb5d5fe6-6b6a-4a45-8723-ed8068bda89b	 	 

 

Dan
Croft

dan.croft@hp.com

Director
of IP Sales and Licensing

HP
Central Account 2

Security
Level: Email, Account Authentication

(None)

Electronic
Record and Signature Disclosure:

Not
Offered

ID: 

 

	In Person Signer Events	Signature 	Timestamp
	Editor Delivery Events	Status	Timestamp
	Agent Delivery Events	Status	Timestamp
	Intermediary Delivery Events	Status	Timestamp
	Certified Delivery Events	Status	Timestamp
	Carbon Copy Events	Status	Timestamp
	Notary	Events	Timestamp
	Envelope Summary Events	Status	Timestamps
	Envelope Sent	Hashed/Encrypted	1/29/2016 7:33:53 AM
	Electronic Record and Signature Disclosure	 	 

 

     

     

    

 

ELECTRONIC
RECORD AND SIGNATURE DISCLOSURE

 

From
time to time, Americas Sales/Alliance Data (we, us or Company) may be required by law to provide to you certain written notices
or disclosures. Described below are the terms and conditions for providing to you such notices and disclosures electronically
through the DocuSign, Inc. (DocuSign) electronic signing system. Please read the information below carefully and thoroughly, and
if you can access this information electronically to your satisfaction and agree to these terms and conditions, please confirm
your agreement by clicking the ‘I agree’ button at the bottom of this document.

 

Getting
paper copies

 

At
any time, you may request from us a paper copy of any record provided or made available electronically to you by us. You will
have the ability to download and print documents we send to you through the DocuSign system during and immediately after signing
session and, if you elect to create a DocuSign signer account, you may access them for a limited period of time (usually 30 days)
after such documents are first sent to you. After such time, if you wish for us to send you paper copies of any such documents
from our office to you, you will be charged a $0.00 per-page fee. You may request delivery of such paper copies from us by following
the procedure described below.

 

Withdrawing
your consent

 

If
you decide to receive notices and disclosures from us electronically, you may at any time change your mind and tell us that thereafter
you want to receive required notices and disclosures only in paper format. How you must inform us of your decision to receive
future notices and disclosure in paper format and withdraw your consent to receive notices and disclosures electronically is described
below.

 

Consequences
of changing your mind

 

If
you elect to receive required notices and disclosures only in paper format, it will slow the speed at which we can complete certain
steps in transactions with you and delivering services to you because we will need first to send the required notices or disclosures
to you in paper format, and then wait until we receive back from you your acknowledgment of your receipt of such paper notices
or disclosures. To indicate to us that you are changing your mind, you must withdraw your consent using the DocuSign ‘Withdraw
Consent’ form on the signing page of a DocuSign envelope instead of signing it. This will indicate to us that you have withdrawn
your consent to receive required notices and disclosures electronically from us and you will no longer be able to use the DocuSign
system to receive required notices and consents electronically from us or to sign electronically documents from us.

 

All
notices and disclosures will be sent to you electronically

 

Unless
you tell us otherwise in accordance with the procedures described herein, we will provide electronically to you through the DocuSign
system all required notices, disclosures, authorizations, acknowledgements, and other documents that are required to be provided
or made available to you during the course of our relationship with you. To reduce the chance of you inadvertently not receiving
any notice or disclosure, we prefer to provide all of the required notices and disclosures to you by the same method and to the
same address that you have given us. Thus, you can receive all the disclosures and notices electronically or in paper format through
the paper mail delivery system. If you do not agree with this process, please let us know as described below. Please also see
the paragraph immediately above that describes the consequences of your electing not to receive delivery of the notices and disclosures
electronically from us.

 

     

     

    

 

How
to contact Americas Sales/Alliance Data:

 

You
may contact us to let us know of your changes as to how we may contact you electronically, to request paper copies of certain
information from us, and to withdraw your prior consent to receive notices and disclosures electronically as follows:

 

To
contact us by email send messages to: christopher.nix@hp.com

 

To
advise Americas Sales/Alliance Data of your new e-mail address

 

To
let us know of a change in your e-mail address where we should send notices and disclosures electronically to you, you must send
an email message to us at christopher.nix@hp.com and in the body of such request you must state: your previous e-mail address,
your new e-mail address. We do not require any other information from you to change your email address.

 

In
addition, you must notify DocuSign, Inc. to arrange for your new email address to be reflected in your DocuSign account by following
the process for changing e-mail in the DocuSign system. To request paper copies from Americas Sales/Alliance Data

 

To
request delivery from us of paper copies of the notices and disclosures previously provided by us to you electronically, you must
send us an e-mail to christopher.nix@hp.com and in the body of such request you must state your e-mail address, full name, US
Postal address, and telephone number. We will bill you for any fees at that time, if any.

 

To
withdraw your consent with Americas Sales/Alliance Data

 

To
inform us that you no longer want to receive future notices and disclosures in electronic format you may:

 

i.
decline to sign a document from within your DocuSign session, and on the subsequent page, select the check-box indicating you
wish to withdraw your consent, or you may;

 

ii. send
us an e-mail to christopher.nix@hp.com and in the body of such request you must state your e-mail, full name, US Postal Address,
and telephone number. We do not need any other information from you to withdraw consent. The consequences of your withdrawing
consent for online documents will be that transactions may take a longer time to process.

 

Required
hardware and software

 

	Operating
    Systems:	Windows®
    2000, Windows® XP, Windows Vista®; Mac OS® X
	Browsers:	Final
    release versions of Internet Explorer® 6.0 or above (Windows only); Mozilla Firefox 2.0 or above (Windows and Mac); SafariTM
    3.0 or above (Mac only)
	PDF
    Reader:	Acrobat®
    or similar software may be required to view and print PDF files
	Screen
    Resolution:	800
    x 600 minimum
	Enabled
    Security Settings:	Allow
    per session cookies

 

**
These minimum requirements are subject to change. If these requirements change, you will be asked to re-accept the disclosure.
Pre-release (e.g. beta) versions of operating systems and browsers are not supported.

  

     

     

    

 

Acknowledging
your access and consent to receive materials electronically

 

To
confirm to us that you can access this information electronically, which will be similar to other electronic notices and disclosures
that we will provide to you, please verify that you were able to read this electronic disclosure and that you also were able to
print on paper or electronically save this page for your future reference and access or that you were able to e-mail this disclosure
and consent to an address where you will be able to print on paper or save it for your future reference and access. Further, if
you consent to receiving notices and disclosures exclusively in electronic format on the terms and conditions described above,
please let us know by clicking the ‘I agree’ button below.

 

By
checking the ‘I agree’ box, I confirm that:

 

	 	●	I
    can access and read this Electronic CONSENT TO ELECTRONIC RECEIPT OF ELECTRONIC RECORD AND SIGNATURE DISCLOSURES document;
    and

 

	 	●	I
    can print on paper the disclosure or save or send the disclosure to a place where I can print it, for future reference and
    access; and

 

	 	●	Until
    or unless I notify Americas Sales/Alliance Data as described above, I consent to receive from exclusively through electronic
    means all notices, disclosures, authorizations, acknowledgements, and other documents that are required to be provided or
    made available to me by Americas Sales/Alliance Data during the course of my relationship with you.

 

     

     

    

 

SECOND AMENDMENT TO THE INTELLECTUAL
PROPERTY AGREEMENT

 

THIS SECOND AMENDMENT TO THE INTELLECTUAL
PROPERTY AGREEMENT (this “Second Amendment”), dated May 1, 2017 (the “Second Amendment Effective
Date”) is an amendment to a certain Intellectual Property Agreement (the “Agreement”) effective
January 31, 2016 (the “Effective Date”) and first amended on April 12, 2016, by and between (a) Hewlett-Packard
Development Company, L.P., a Texas limited partnership having its principal place of business at 11445 Compaq Drive West, Houston,
Texas 77070-1443 (“HPDC”), and HP, Inc., a Delaware corporation having its principal place of business
at 1501 Page Mill Road, Palo Alto, California 94304, U.S.A. (“HPI”) (HPDC and HPI are collectively referred
to herein as “HP”), on the one hand; and (b) 3D Nanocolor Corp., a Delaware corporation having its principal
place of business at 11100 Santa Monica Blvd Suite 380, Los Angeles, CA 90025 U.S.A. (“Company”) (each
individually referred to as a “Party” and both collectively referred to as the “Parties”).

 

RECITALS

 

WHEREAS the Parties desire to amend the Agreement.

 

NOW, THEREFORE, the Parties agree to amend the Agreement
as follows:

 

		A.	Replace Section 1.5 in its entirety with the following:

 

		1.5	“Closing Date” is four (4) years from the Effective
Date, or such longer period as the Parties may agree, and further subject to the provisions of Section 2.3.

 

		B.	Replace Section 2.4 in its entirety with the following:

 

		2.4	Covenant Not
                                         to License. For four (4) years from the Effective Date, other than as set forth in
                                         this Section 2.4, HP agrees not to license, transfer, pledge, offer to option encumber,
                                         sell, assign or otherwise dispose of the HP Technology, or the Assignable Patents to
                                         any Third Party. The foregoing shall not apply to: (i) licenses executed prior to the
                                         Effective Date or options to license executed prior to the Effective Date that are exercised
                                         thereafter; (ii) patent cross-licenses or broad licenses, regardless of their execution
                                         date, that do not specifically (a) enumerate the Assignable Patents or (b) otherwise
                                         contemplate disclosure of the HP Technology; or (iii) litigation settlement agreements
                                         between HP or its Subsidiaries and any Third Party.

 

		C.	Replace Section 4.1 in its entirety with the following:

 

		4.1	Research License
                                         Fee. Company shall pay HP the non-refundable, non-creditable amount of Three Hundred
                                         Seventy-Five Thousand Dollars and Zero Cents (U.S.$375,000.00) payable in accordance
                                         with the following schedule:

 

		4.1.1 	Seventy-Five Thousand Dollars and Zero Cents (U.S.$75,000.00)
upon completion of the technology transfer contemplated under Section 2.1; and

 

	CONFIDENTIAL	1/2	 

3D Nanocolor– HP: IP Agreement Second Amendment

 

    	 	 	 

     

    

 

		4.1.2 	One Hundred Thousand Dollars and Zero Cents (U.S.$100,000.00)
upon the first anniversary of the Effective Date.

 

		4.1.3 	One Hundred Thousand Dollars and Zero Cents (U.S.$100,000.00)
upon the second anniversary of the Effective Date.

 

		4.1.4  	One Hundred Thousand Dollars and Zero Cents (U.S.$100,000.00)
upon the third anniversary of the Effective Date. 

 

D. All other terms and conditions of the Agreement remain in
effect.

 

IN WITNESS WHEREOF, the Parties
hereto have duly executed this Second Amendment, as of the date set forth in the first paragraph hereof.

 

	“HPI”	 	“Company”
	HP INC.	 	3D Nanocolor Corp.
	 	 	 
	Signature: 	/s/ Annette Friskopp	 	Signature: 	/s/ Tim Koch
	 	 	 	 	 
	Name: 	Annette Friskopp	 	Name: 	Tim Koch
	 	 	 	 	 
	Title: 	GM HP SPS	 	Title: 	Chief Technology Officier
	 	 	 
	“HPDC”	 	 
	Hewlett-Packard Development Company, L.P.	 	 
	By: HPQ Holdings, LLC, its General Partner	 	 
	 	 	 
	Signature:	/s/ Dan Croft	 	 
	 	 	 	 
	Name: 	Dan Croft	 	 
	 	 	 	 
	Title: 	Head of IP Sales & Licensing	 	 

 

	CONFIDENTIAL	2/2	 

3D Nanocolor– HP: IP Agreement Second AmendmentExhibit 10.3

 

Amendment
to Agreement

 

This
Amendment made and entered into as of this 2nd day of July, 2018, by and between Crown Electrokinetics Corp., a corporation
of Delaware, having its principal place of business at 1110NE Circle Blvd., Corvallis, OR 97330, the U.S.A. (hereinafter referred
to as the “COMPANY”) and AGC Inc., a corporation of Japan, having its principal place of business at 5-1, Marunouchi
1-chome, Chiyoda-ku, Tokyo 100-8405 Japan, including AGC Business Development Americas, a division of AGC Flat Glass North America,
Inc. (collectively hereinafter referred to as “AGC”),

 

WITNESSETH:

 

WHEREAS,
the COMPANY and AGC entered into “Agreement” as of the 15th day of November, 2017 (hereinafter referred to
as “Original Agreement”), under which the COMPANY agreed to provide Samples of Phase 1 (as defined in Original Agreement)
to AGC and in six (6) months from the Effective Date (as defined in Original Agreement; the 15th day of November, 2017),
and

 

WEREAS,
the COMPANY failed to provide those Samples by the day on which the COMPANY agreed to provide the Samples and requested AGC to
extend its due date of the provision of the Samples, and AGC accepted such request,

  

NOW THEREFORE, in consideration of the mutual
covenants and agreements herein contained, the parties hereto agree as follows:

 

Article
1 Amendment to Section 1 of the Original Agreement

The
phrase “in six (6) months from the Effective Date” in Section 1 of the Original Agreement shall be replaced in its entirety
with “by the 30th day of September, 2018”.

 

Article
2 Effective Date

This
Amendment shall retroactively come into effect on the 14th day of May, 2018.

 

Article
3 Full Force and Effect

Except
as otherwise modified herein, all other terms and conditions of the Original Agreement shall remain unchanged.

 

IN
WITNESS WHEREOF, the parties have caused this Amendment to be executed by their respective duly authorized representatives as
of the date first written above.

 

	COMPANY	 	 	AGC	 
	 	 	 	 	 
	BY:	/s/
    James Douvikas	 	BY:	/s/
    Hiroki Kamiya
	NAME:	James Douvikas	 	NAME:	Hiroki
    Kamiya
	TITLE:	CEO	 	TITLE:	GM
    Planning Division Technology General Division

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}]]